Ghp Investment Advisors, Inc. Bristol Myers Squibb CO Transaction History

Ghp Investment Advisors, Inc.

$1.99 Billion
Q2 2024

A detailed history of Ghp Investment Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ghp Investment Advisors, Inc. holds 5,980 shares of BMY stock, worth $318,076. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,980

Previous 5,980 -0.0%

Holding current value

$318,076

Previous $324,000 23.46%

% of portfolio

0.01%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	SELL	$48.48 - $57.85 $4,654 - $5,553	-96 Reduced 1.58%	5,980 $306,000
Q3 2023 Oct 17, 2023	BUY	$57.89 - $64.73 $22,345 - $24,985	386 Added 6.78%	6,076 $352,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $2,293 - $2,546	-36 Reduced 0.63%	5,690 $363,000
Q1 2023 Apr 21, 2023	BUY	$65.71 - $74.53 $1,774 - $2,012	27 Added 0.47%	5,726 $396,000
Q4 2022 Feb 16, 2023	BUY	$68.48 - $81.09 $5,889 - $6,973	86 Added 1.53%	5,699 $409,000
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $8,206 - $9,037	-113 Reduced 1.97%	5,613 $432,000
Q1 2022 Apr 28, 2022	BUY	$61.48 - $73.72 $11,066 - $13,269	180 Added 3.25%	5,726 $418,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $65,804 - $76,712	-1,227 Reduced 18.12%	5,546 $346,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $7,800 - $8,494	-126 Reduced 1.83%	6,773 $453,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $11,096 - $12,480	-187 Reduced 2.64%	6,899 $436,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $18,188 - $20,610	315 Added 4.65%	7,086 $440,000
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $3,158 - $3,500	55 Added 0.82%	6,771 $408,000
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $217,361 - $254,116	-3,965 Reduced 37.12%	6,716 $395,000
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $21,390 - $31,085	461 Added 4.51%	10,681 $595,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $268,686 - $350,477	5,460 Added 114.71%	10,220 $656,000
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $1,069 - $1,267	-25 Reduced 0.52%	4,760 $241,000
Q2 2019 Aug 02, 2019	BUY	$44.62 - $49.34 $1,115 - $1,233	25 Added 0.53%	4,785 $217,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $2,438 - $3,161	-50 Reduced 1.04%	4,760 $247,000
Q2 2018 Aug 17, 2018	SELL	$50.53 - $62.98 $2,526 - $3,149	-50 Reduced 1.03%	4,810 $266,000
Q1 2018 Apr 25, 2018	SELL	$59.92 - $68.98 $27,982 - $32,213	-467 Reduced 8.77%	4,860 $307,000
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $14,145 - $15,422	-236 Reduced 4.24%	5,327 $326,000
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $307,244 - $354,585	5,563	5,563 $355,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghp Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ghp Investment Advisors, Inc. with notifications on news.

Account

Ghp Investment Advisors, Inc. Bristol Myers Squibb CO Transaction History